http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#Head http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#assertion http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#provenance http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#pubinfo http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#assertion http://purl.obolibrary.org/obo/DOID_10718 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10718 http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00911 http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association http://www.w3.org/2000/01/rdf-schema#label tinidazole is a nitroimidazole antimicrobial indicated for 1 1 1 2 1 3 1 4 8 1 to reduce the development of drug resistant bacteria and maintain the effectiveness of tinidazole and other antibacterial drugs tinidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria 1 5 tinidazole is indicated for the treatment of trichomoniasis caused by trichomonas vaginalis see clinical studies 14 1 tinidazole is indicated for the treatment of giardiasis caused by giardia duodenalis g lamblia see clinical studies 14 2 tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by entamoeba histolytica see clinical studies 14 3 14 4 tinidazole is indicated for the treatment of bacterial vaginosis formerly referred to as haemophilus gardnerella adult women see use in specific populations 8 1 14 5 other pathogens commonly associated with vulvovaginitis such as trichomonas vaginalis chlamydia trachomatis neisseria gonorrhoeae candida albicans herpes simplex to reduce the development of drug resistant bacteria and maintain the effectiveness of tinidazole and other antibacterial drugs tinidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00911 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#provenance http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#pubinfo http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#sig http://purl.org/nanopub/x/hasSignature ipYFGw5fc3EYxXKWEM21LMOBFpLrnIwZbRYo7L2Dvbcs4ELXYYxvcVIeKK7yy4rg0qhCCv+lq4v2PgqXsEk1N7nFFAXKNbO5Xwx22Ymd5hK05X9LSXfwvlbK+x/mvJJDAr9XU+RXgwtzIsJk2thCul+kta1uv8Zmpp+v5f6DCsc= http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://purl.org/dc/terms/created 2021-07-03T13:00:40.189+02:00 http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAP7q4lGz8j8IfJpIQTj2uB04QhLtmQBFcIc03R9ii8tg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs